Granulocyte-macrophage colony stimulating factor from human lymphocytes. The effect of glycosylation on receptor binding and biological activity
- PMID: 2155231
Granulocyte-macrophage colony stimulating factor from human lymphocytes. The effect of glycosylation on receptor binding and biological activity
Abstract
Native human granulocyte-macrophage colony stimulating factor (hGM-CSF) has previously been purified using methods which typically required several sequential chromatographic steps and only yielded small amounts of hGM-CSF. We have purified and characterized hGM-CSF using monoclonal antibodies raised against bacterially synthesized hGM-CSF. Activated donor T-lymphocytes grown in interleukin-2 and then reactivated with phytohemagglutinin produce several forms of hGM-CSF which can be purified using immunoaffinity absorption followed by reversed phase high performance liquid chromatography. The purified hGM-CSF consisted of at least nine species ranging in molecular weight (Mr) from 14,500 to 32,000. The higher Mr forms contained one or two N-linked carbohydrate moieties and were more acidic by two-dimensional Western blot analysis, consistent with increasing sialation. N-terminal sequence analysis of high and low molecular weight hGM-CSF fractions corresponded to that predicted by the cDNA sequence. Using the AML 193 [3H]thymidine incorporation assay the specific activity of the heavily glycosylated hGM-CSF was 1 x 10(8) units/mg compared with 6 x 10(8) units/mg for the non-glycosylated hGM-CSF produced by Escherichia coli. The different hGM-CSF forms induced neutrophil superoxide anion production by a variable amount depending on the extent of N-linked glycosylation. Receptor binding studies demonstrated lower receptor affinity for the heavily glycosylated form (KD = 820 pM) compared to less heavily glycosylated (KD = 78 pM) and non-glycosylated hGM-CSF produced by E. coli (KD = 30 pM). These differences are due to differences in the kinetic association rate.
Similar articles
-
Purification and characterization of three forms of differently glycosylated recombinant human granulocyte-macrophage colony-stimulating factor.Arch Biochem Biophys. 1991 May 1;286(2):562-8. doi: 10.1016/0003-9861(91)90080-3. Arch Biochem Biophys. 1991. PMID: 1897978
-
Common binding structure for granulocyte macrophage colony-stimulating factor and interleukin-3 on human acute myeloid leukemia cells and monocytes.Blood. 1990 Apr 1;75(7):1439-45. Blood. 1990. PMID: 2156580
-
Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor.EMBO J. 1989 Dec 1;8(12):3667-76. doi: 10.1002/j.1460-2075.1989.tb08541.x. EMBO J. 1989. PMID: 2555171 Free PMC article.
-
Enhancement of release of granulocyte- and granulocyte-macrophage colony-stimulating factors from phytohemagglutinin-stimulated sorted subsets of human T lymphocytes by recombinant human tumor necrosis factor-alpha. Synergism with recombinant human IFN-gamma.J Immunol. 1988 Jul 1;141(1):201-7. J Immunol. 1988. PMID: 2454257
-
Regulation of surface expression of the granulocyte/macrophage colony-stimulating factor receptor in normal human myeloid cells.Proc Natl Acad Sci U S A. 1990 Jan;87(1):93-7. doi: 10.1073/pnas.87.1.93. Proc Natl Acad Sci U S A. 1990. PMID: 2153304 Free PMC article.
Cited by
-
IFN-γ-independent control of M. tuberculosis requires CD4 T cell-derived GM-CSF and activation of HIF-1α.PLoS Pathog. 2022 Jul 25;18(7):e1010721. doi: 10.1371/journal.ppat.1010721. eCollection 2022 Jul. PLoS Pathog. 2022. PMID: 35877763 Free PMC article.
-
GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review.Int J Mol Sci. 2022 Jul 1;23(13):7373. doi: 10.3390/ijms23137373. Int J Mol Sci. 2022. PMID: 35806376 Free PMC article. Review.
-
Construction of Recombinant Human GM-CSF and GM-CSF-ApoA-I Fusion Protein and Evaluation of Their Biological Activity.Pharmaceuticals (Basel). 2021 May 13;14(5):459. doi: 10.3390/ph14050459. Pharmaceuticals (Basel). 2021. PMID: 34068113 Free PMC article.
-
Soluble Prokaryotic Overexpression and Purification of Human GM-CSF Using the Protein Disulfide Isomerase b'a' Domain.Int J Mol Sci. 2021 May 17;22(10):5267. doi: 10.3390/ijms22105267. Int J Mol Sci. 2021. PMID: 34067755 Free PMC article.
-
Mimicking Behçet's disease: GM-CSF gain of function mutation in a family suffering from a Behçet's disease-like disorder marked by extreme pathergy.Clin Exp Immunol. 2021 May;204(2):189-198. doi: 10.1111/cei.13568. Epub 2021 Jan 28. Clin Exp Immunol. 2021. PMID: 33349924 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources